Healthcare provider profile · identity verified

Frederick Paul Benson, M.D.

Family Practice · SAN JOSE, CA · NPI 1245240993

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	123
Amlodipine Besylate	Amlodipine Besylate	285	72
Levothyroxine Sodium	Levothyroxine Sodium	279	70
Losartan Potassium	Losartan Potassium	268	80
Rosuvastatin Calcium	Rosuvastatin Calcium	192	59
Zolpidem Tartrate	Zolpidem Tartrate	169	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	160	40
Simvastatin	Simvastatin	152	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	149	41
Gabapentin	Gabapentin	147	47
Lisinopril	Lisinopril	146	40
Metformin Hcl Er	Metformin Hcl	130	40
Metoprolol Succinate	Metoprolol Succinate	117	28
Albuterol Sulfate Hfa	Albuterol Sulfate	105	35
Lorazepam	Lorazepam	102	26
Hydrochlorothiazide	Hydrochlorothiazide	99	30
Tamsulosin Hcl	Tamsulosin Hcl	96	29
Alprazolam	Alprazolam	94	27
Citalopram Hbr	Citalopram Hydrobromide	94	25
Pantoprazole Sodium	Pantoprazole Sodium	91	26
Glimepiride	Glimepiride	89	23
Azithromycin	Azithromycin	88	72
Trazodone Hcl	Trazodone Hcl	83	27
Omeprazole	Omeprazole	81	24
Olmesartan Medoxomil	Olmesartan Medoxomil	69	21
Pravastatin Sodium	Pravastatin Sodium	63	18
Ozempic	Semaglutide	62	16
Metformin Hcl	Metformin Hcl	61	17
Triamcinolone Acetonide	Triamcinolone Acetonide	61	32
Famotidine	Famotidine	59	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	44
Tramadol Hcl	Tramadol Hcl	56	suppressed
Allopurinol	Allopurinol	55	17
Sertraline Hcl	Sertraline Hcl	53	17
Furosemide	Furosemide	51	15
Bupropion Xl	Bupropion Hcl	49	19
Valacyclovir	Valacyclovir Hcl	48	19
Oxybutynin Chloride Er	Oxybutynin Chloride	45	17
Clonazepam	Clonazepam	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Prednisone	Prednisone	38	31
Carvedilol	Carvedilol	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	14
Celecoxib	Celecoxib	34	12
Donepezil Hcl	Donepezil Hcl	34	suppressed
Finasteride	Finasteride	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Cefuroxime	Cefuroxime Axetil	30	25
Potassium Chloride	Potassium Chloride	30	suppressed
Eliquis	Apixaban	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	28
Clopidogrel	Clopidogrel Bisulfate	28	11
Estradiol	Estradiol	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	16
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Atenolol	Atenolol	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Ofloxacin	Ofloxacin	22	suppressed
Ondansetron Odt	Ondansetron	22	11
Meloxicam	Meloxicam	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	20	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Cephalexin	Cephalexin	16	15
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Testosterone	Testosterone	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Naproxen	Naproxen	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Dupixent Syringe	Dupilumab	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Gemtesa	Vibegron	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methimazole	Methimazole	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error